Is Your Product a Cosmetic or a Drug? FDA Classification for Foreign Brands

By Vincent Cruz

Many foreign brands assume that if a product looks like a cosmetic, FDA treats it as one. That assumption has sunk more than a few U.S. launches. Under American law, a moisturizer with SPF, an acne serum, or a “skin repair” cream can be legally classified as a drug, and drugs play by entirely different rules.

Getting this wrong is expensive. If your product is actually a drug, filing it as a cosmetic through Cosmetics Direct does not make you compliant. This guide explains how FDA decides what your product is, the borderline cases that trap foreign brands, and what changes when the answer is “drug.” For the full compliance picture, start with the MoCRA Compliance Guide for Cosmetic Brands.

Why classification comes first

Everything else in U.S. compliance flows from this one determination. Cosmetics follow MoCRA: facility registration, product listing, safety substantiation, adverse event reporting, labeling rules. Drugs follow a separate, stricter regime: establishment registration and drug listing in a different FDA system, Drug Facts labeling, manufacturing under drug current Good Manufacturing Practice (21 CFR parts 210 and 211), and for many categories, premarket approval or compliance with an OTC monograph.

A product can also be both at once. An antidandruff shampoo cleanses hair (cosmetic) and treats dandruff (drug). A moisturizer with sunscreen moisturizes (cosmetic) and protects against sunburn (drug). Combination products must satisfy both sets of requirements.

The practical point: classify before you file anything. A facility registration and product listing for a product that is legally a drug give you no protection at all.

How FDA decides: intended use

FDA does not classify products by what they look like or what category you assign them. It classifies by intended use, determined from three sources:

1. Claims on labeling and advertising. What you say the product does is the single biggest factor. “Reduces the appearance of fine lines” is a cosmetic claim (appearance). “Repairs damaged skin cells” or “stimulates collagen production” is a drug claim (affects structure or function of the body). “Prevents acne” or “treats blemishes” is a drug claim (treats a disease condition). The exact words matter enormously.

2. Consumer perception. If the product name, imagery, or overall presentation implies a therapeutic effect, FDA can treat that as evidence of drug intent even if the text claims are careful.

3. Ingredients with well-known therapeutic use. Some ingredients are so closely associated with drug effects that their presence signals drug intent. Fluoride in toothpaste, for example, makes it a drug regardless of what the label says.

The legal definitions: a cosmetic is an article intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance. A drug is an article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, or intended to affect the structure or any function of the body.

The borderline cases that trap foreign brands

These are the products where foreign brands most often misclassify:

Sunscreen and SPF products. In the U.S., sunscreen active ingredients are drugs. Any product claiming sun protection, including a moisturizer or lip balm “with SPF 30,” is a drug (or a drug-cosmetic combination). This surprises many brands because in the EU and much of Asia, sunscreens are regulated as cosmetics. The U.S. is different, full stop.

Acne products. Anything claiming to treat, prevent, or reduce acne is a drug. “For acne-prone skin” as a description of the target user is generally cosmetic; “clears breakouts” or “fights acne” crosses the line.

Skin lightening and whitening. This is nuanced. A product that claims to lighten the overall appearance of skin through exfoliation or optical brightening is generally a cosmetic. But products containing ingredients like hydroquinone, or claiming to treat hyperpigmentation, melasma, or dark spots as conditions, move into drug territory. Tread carefully with any whitening claim aimed at the U.S. market.

Anti-aging and “repair” claims. “Reduces the appearance of wrinkles” is cosmetic. “Rebuilds skin elasticity,” “boosts collagen,” or “repairs DNA damage” affects structure or function and is a drug claim. Marketing teams love these words; regulatory teams fear them.

Hair loss and hair growth. Any claim about regrowing hair, preventing hair loss, or stimulating follicles is a drug claim. Cosmetic hair products can claim to make hair look thicker or fuller.

Antiperspirants and deodorants. Deodorants that only mask odor are cosmetics. Antiperspirants that reduce perspiration affect a bodily function and are drugs.

“Cosmeceuticals.” This word appears constantly in industry marketing and means nothing in U.S. law. FDA does not recognize the category. Your product is a cosmetic, a drug, or both, regardless of what your marketing calls it.

Soap. True soap is actually excluded from the cosmetic definition entirely, but only if it meets a narrow test: the bulk of the product is alkali salts of fatty acids, it is labeled and marketed only as soap, and it makes no cosmetic or drug claims beyond cleansing. Most modern “soap” bars with moisturizing or deodorizing claims do not qualify.

What changes if your product is a drug

If classification lands on “drug,” the compliance path changes completely:

• Registration and listing happen in FDA’s drug establishment registration and listing system, not Cosmetics Direct. MoCRA filings do not cover drugs.
• Labeling must follow drug labeling rules, including the standardized Drug Facts panel for OTC drugs. Cosmetic labeling rules do not apply.
• Manufacturing must follow drug cGMP under 21 CFR parts 210 and 211, which is far more prescriptive than anything currently required for cosmetics.
• Premarket requirements may apply. Many OTC drug categories are covered by monographs that set permitted ingredients, doses, and labeling. Products outside a monograph generally need an approved new drug application.
• Your U.S. agent arrangement may need revisiting. The agent designated for your cosmetic facility registration is a MoCRA concept; drug imports have their own entry and compliance mechanics.

None of this is DIY territory for most foreign brands. If your product is a drug, you need regulatory counsel or a specialized consultant before you ship.

Getting it right before you launch

• Audit every claim on your labels, website, Amazon listings, and social media against the cosmetic/drug line. Marketing copy written for the EU or Korean market routinely contains claims that are drug claims in the U.S.
• Check your ingredients against FDA’s lists. Sunscreen actives, acne actives, and other drug ingredients trigger drug status by their presence.
• Decide deliberately. If a product sits on the borderline, you have two legitimate options: reformulate or reword the claims to stay a cosmetic, or accept drug status and comply as a drug. What you cannot do is file it as a cosmetic and hope nobody notices.
• Remember that marketplaces do not decide for you. Getting listed on Amazon or TikTok Shop says nothing about whether FDA considers your product compliant. See Selling Cosmetics on Amazon USA: FDA Requirements and FDA Certificate for TikTok Shop.

FAQ

Who decides whether my product is a cosmetic or a drug?
FDA does, based on intended use as shown by your claims, labeling, advertising, and ingredients. Your own categorization does not control the outcome.

My product is sold as a cosmetic in the EU. Is it automatically a cosmetic in the US?
No. The U.S. and EU draw the line differently. The biggest divergence is sunscreen: regulated as a cosmetic in the EU, as a drug in the U.S. Always re-evaluate classification specifically for the American market.

Can one product be both a cosmetic and a drug?
Yes. Products with both cosmetic and drug intended uses, like antidandruff shampoo or moisturizer with SPF, must comply with the requirements for both categories.

Does “cosmeceutical” mean anything to FDA?
No. It is a marketing term with no legal definition. FDA classifies the product as a cosmetic, a drug, or both based on intended use.

If my product is a drug, can I still use a MoCRA U.S. agent?
The MoCRA U.S. agent is specific to cosmetic facility registration. Drug products have separate FDA registration, listing, and import requirements. Discuss your situation with a regulatory professional; see Who Can Be a MoCRA U.S. Agent for what the agent role covers.

What happens if I file a drug product as a cosmetic?
The filings do not make the product compliant. FDA can detain the shipment at import, issue a warning letter, and treat the product as an unapproved new drug or misbranded drug, which carries far heavier consequences than cosmetic non-compliance. See FDA Detained My Cosmetic Shipment.

---

Next step: Unsure how your products classify? Contact us and describe your product and its claims; we will give you a straight read on whether you are looking at a cosmetic, a drug, or both. You can also run the free FEI check to confirm your facility’s FDA standing.